Efficacy, Safety, and Impact on the Quality of Life
of Guselkumab in the Treatment of Moderate-to-Severe Plaque
Psoriasis and Psoriatic Arthritis

Szymon Smereka; Wiktor Jabłoński; Julia Raszewska; Natalia Wolińska; Caterina Riccardi

doi:10.5114/dr.2025.158595

Streszczenie

5/2025 vol. 112

Artykuł przeglądowy

Efficacy, Safety, and Impact on the Quality of Life of Guselkumab in the Treatment of Moderate-to-Severe Plaque Psoriasis and Psoriatic Arthritis

Szymon Smereka ¹

,

Wiktor Jabłoński ²

,

Julia Raszewska ³

,

Natalia Wolińska ⁴

,

Caterina Riccardi ⁵

Junior Physician, Municipal Specialist Hospital named after G. Narutowicza, Krakow, Poland
Junior Physician, Stefan Żeromski Specialist Hospital, SP ZOZ, Krakow, Poland
6th-Year Medical Student, Andrzej Frycz Modrzewski Krakow University, Krakow, Poland
Junior Physician, Beskid Oncology Center - Municipal Hospital named after John Paul II, Bielsko-Biala, Poland
Junior Physician, University Hospital, Krakow, Poland

Dermatol Rev/Przegl Dermatol 2025, 112, 301-305

DOI: https://doi.org/10.5114/dr.2025.158595

Data publikacji online: 2025/12/30

Pełna treść artykułu

AMA

Smereka S, Jabłoński W, Raszewska J, Wolińska N, Riccardi C. Efficacy, Safety, and Impact on the Quality of Life of Guselkumab in the Treatment of Moderate-to-Severe Plaque Psoriasis and Psoriatic Arthritis. Dermatology Review/Przegląd Dermatologiczny. 2025;112(5):301-305. doi:10.5114/dr.2025.158595.

APA

Smereka, S., Jabłoński, W., Raszewska, J., Wolińska, N., & Riccardi, C. (2025). Efficacy, Safety, and Impact on the Quality of Life of Guselkumab in the Treatment of Moderate-to-Severe Plaque Psoriasis and Psoriatic Arthritis. Dermatology Review/Przegląd Dermatologiczny, 112(5), 301-305. https://doi.org/10.5114/dr.2025.158595

Chicago

Smereka, Szymon, Wiktor Jabłoński, Julia Raszewska, Natalia Wolińska, and Caterina Riccardi. 2025. "Efficacy, Safety, and Impact on the Quality of Life of Guselkumab in the Treatment of Moderate-to-Severe Plaque Psoriasis and Psoriatic Arthritis". Dermatology Review/Przegląd Dermatologiczny 112 (5): 301-305. doi:10.5114/dr.2025.158595.

Harvard

Smereka, S., Jabłoński, W., Raszewska, J., Wolińska, N., and Riccardi, C. (2025). Efficacy, Safety, and Impact on the Quality of Life of Guselkumab in the Treatment of Moderate-to-Severe Plaque Psoriasis and Psoriatic Arthritis. Dermatology Review/Przegląd Dermatologiczny, 112(5), pp.301-305. https://doi.org/10.5114/dr.2025.158595

MLA

Smereka, Szymon et al. "Efficacy, Safety, and Impact on the Quality of Life of Guselkumab in the Treatment of Moderate-to-Severe Plaque Psoriasis and Psoriatic Arthritis." Dermatology Review/Przegląd Dermatologiczny, vol. 112, no. 5, 2025, pp. 301-305. doi:10.5114/dr.2025.158595.

Vancouver

Smereka S, Jabłoński W, Raszewska J, Wolińska N, Riccardi C. Efficacy, Safety, and Impact on the Quality of Life of Guselkumab in the Treatment of Moderate-to-Severe Plaque Psoriasis and Psoriatic Arthritis. Dermatology Review/Przegląd Dermatologiczny. 2025;112(5):301-305. doi:10.5114/dr.2025.158595.

Streszczenie

Efficacy, Safety, and Impact on the Quality of Life of Guselkumab in the Treatment of Moderate-to-Severe Plaque Psoriasis and Psoriatic Arthritis

Udostępnij

Dostępne w

Zintergrowane z

Zasady redakcyjne